{"id":111412,"date":"2024-08-09T18:54:09","date_gmt":"2024-08-09T18:54:09","guid":{"rendered":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/08\/09\/merck-buying-drug-targeting-b-cell-diseases-for-up-to-1-3-billion\/"},"modified":"2024-08-09T18:54:09","modified_gmt":"2024-08-09T18:54:09","slug":"merck-buying-drug-targeting-b-cell-diseases-for-up-to-1-3-billion","status":"publish","type":"post","link":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/08\/09\/merck-buying-drug-targeting-b-cell-diseases-for-up-to-1-3-billion\/","title":{"rendered":"Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion"},"content":{"rendered":"<div style=\"text-align:center\"><img loading=\"lazy\" decoding=\"async\" width=\"553\" height=\"369\" src=\"https:\/\/i1.wp.com\/images.wsj.net\/im-988268\/medium?resize=553,369&amp;ssl=1\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Merck Buying Drug Targeting B-Cell Diseases for Up to .3 Billion\" title=\"Merck Buying Drug Targeting B-Cell Diseases for Up to .3 Billion\" \/><\/div>\n<p>Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.<br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.wsj.com\/articles\/merck-buying-drug-targeting-b-cell-diseases-for-up-to-1-3-billion-1bff64ee?mod=pls_whats_news_us_business_f\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases. Source link<\/p>\n","protected":false},"author":2,"featured_media":111413,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","fifu_image_url":"https:\/\/images.wsj.net\/im-988268\/medium","fifu_image_alt":"","footnotes":""},"categories":[604],"tags":[91603,1289,10254,10589,1393,33951,14456],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/111412"}],"collection":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/comments?post=111412"}],"version-history":[{"count":1,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/111412\/revisions"}],"predecessor-version":[{"id":111414,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/111412\/revisions\/111414"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media\/111413"}],"wp:attachment":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media?parent=111412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/categories?post=111412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/tags?post=111412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}